Gain valuable insights and knowledge through our free on-demand webinar

First Name
Last Name
Are you a YourEncore Expert or interested in becoming one?
Thank you!
Error - something went wrong!

[WEBINAR] Investor Briefing: 6 Pharma Trends to Watch 2016

November 10, 2016

Emerging Growth Equities and YourEncore Present


The Butterfly Effect, first coined by Edward Lorenz, refers to the concept that small changes can create large downstream effects. Today, the biopharma industry is operating at the tip of a butterfly’s wings.

For this year’s Pharm-ers Almanac, YourEncore assembled a team of top industry experts to discuss areas within the biopharma industry that are poised for disruption that initially may seem insignificant, but could have a large and lasting ripple effect.

In this session, we highlighted the top areas and provide some 'things to watch' as you build or manage your biopharma investments and portfolios.

Topics include:
-Drug-Device Combination Products
-Drug Pricing
-CROs-Sponsor Relationships
-New Regulations
-Drug Quality

Check out the Webinar above for these topics and a Q&A session with our speakers.

About Tim Franson, M.D.: Dr. Franson is the Chief Medical Officer for YourEncore and industry expert in regulatory affairs and drug development policy.  Dr. Franson is the Chairman of the Board for the Critical Path Institute, the Immediate Past President of the USP, and former VP of Global Regulatory Affairs and Patient Safety for Eli Lilly & Company. 

About Don Therasse, M.D.Dr. Therasse is a Strategic Advisor for YourEncore specializing in clinical development, medical affairs and drug safety. He is the former vice president, global patient safety and global medical affairs at Eli Lilly and Company.

Previous Article
9 Biotech Valuation Killers (Ep. 3 of The Pharmcast)
9 Biotech Valuation Killers (Ep. 3 of The Pharmcast)

  This week in the Pharmcast, we discuss "9 Biotech Valuation Killers" with Dr. Brian Daniels...

Next Article
Leading the Bristol-Myers Squibb Transformation (Part 2) (Ep. 2 of The Pharmcast)
Leading the Bristol-Myers Squibb Transformation (Part 2) (Ep. 2 of The Pharmcast)

  A continuation of our maiden voyage of the Pharmcast, we talk with a trio of former Bristol...